Protein RPS19 for the treatment of inflammatory diseases and cancer
With respect to both structure and function, the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF) is a unique mediator of the immune system, whose important role in inflammatory diseases such as septic shock, chronic inflammations and autoimmune diseases such as arthritis, glomerulonephritis, autoimmune encephalitis, and autoimmune diabetes is well known. In this context, the chemotactic effect of MIF on monocytes is an important step of the inflammatory cascade, which is mediated by a binding of MIF to the chemokine receptors CXCR2 and CXCR4.<br>
Our scientific studies now showed for the first time that the ribosomal protein S19 (symbol: RPS19, HGNC ID:10402) is able to inhibit the pro-inflammatory effect of the central mediator of inflammation, the macrophage migration inhibitory factor (MIF), in a receptordependent manner. Further in vitro experiments confirm an interaction of MIF with RPS19.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Why getting in touch with our ‘gerbil brain’ could help machines listen better
Macquarie University researchers have debunked a 75-year-old theory about how humans determine where sounds are coming from, and it could unlock the secret to creating a next generation of more…
Attosecond core-level spectroscopy reveals real-time molecular dynamics
Chemical reactions are complex mechanisms. Many different dynamical processes are involved, affecting both the electrons and the nucleus of the present atoms. Very often the strongly coupled electron and nuclear…
Free-forming organelles help plants adapt to climate change
Scientists uncover how plants “see” shades of light, temperature. Plants’ ability to sense light and temperature, and their ability to adapt to climate change, hinges on free-forming structures in their…
